Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Majed A Refaai

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Annals of Emergency Medicine|June 22, 2015
Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled StudiesTruman J Milling, Majed A Refaai, Joshua N Goldstein, et al.
Transfusion|September 8, 2011
Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidenceKelly F Henrichs, Nedda Howk, Debra S Masel, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 27, 2002
Fatty acid ethyl esters: recent observationsMichael Laposata, Ali Hasaba, Catherine A Best, et al.
US Oncology & Hematology|August 30, 2011
Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro StudyMajed A Refaai, Kelly F Henrichs, Sherry L Spinelli, et al.
Transfusion|June 22, 2010
An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusionsNeil Blumberg, Joanna M Heal, Kelly F Gettings, et al.
Transfusion|May 17, 2020
Evaluation of the procoagulant properties of a newly developed platelet modified lysate productMajed A Refaai, Grace W Conley, Chad A Hudson, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 30, 2016
Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical TrialsTruman J Milling, Majed A Refaai, Ravi Sarode, et al.
Pediatric Cardiology|November 2, 2017
Oxidation Reduction Potential (ORP) is Predictive of Complications Following Pediatric Cardiac SurgeryAmy E Schmidt, Emily Gore, Kelly F Henrichs, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 9, 2023
Reduction of anti-A and anti-B isoagglutinin titers of group O whole blood units employing an ABO antibody immune adsorption columnGaurav K Gupta, Kelly Henrichs, Kurt Nilsson, et al.
Emergency Medicine International|October 24, 2017
Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled TrialsMajed A Refaai, Truptesh H Kothari, Shana Straub, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Annals of Emergency Medicine|June 22, 2015
Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled StudiesTruman J Milling, Majed A Refaai, Joshua N Goldstein, et al.
Transfusion|September 8, 2011
Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidenceKelly F Henrichs, Nedda Howk, Debra S Masel, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 27, 2002
Fatty acid ethyl esters: recent observationsMichael Laposata, Ali Hasaba, Catherine A Best, et al.
US Oncology & Hematology|August 30, 2011
Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro StudyMajed A Refaai, Kelly F Henrichs, Sherry L Spinelli, et al.
Transfusion|June 22, 2010
An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusionsNeil Blumberg, Joanna M Heal, Kelly F Gettings, et al.
Transfusion|May 17, 2020
Evaluation of the procoagulant properties of a newly developed platelet modified lysate productMajed A Refaai, Grace W Conley, Chad A Hudson, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 30, 2016
Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical TrialsTruman J Milling, Majed A Refaai, Ravi Sarode, et al.
Pediatric Cardiology|November 2, 2017
Oxidation Reduction Potential (ORP) is Predictive of Complications Following Pediatric Cardiac SurgeryAmy E Schmidt, Emily Gore, Kelly F Henrichs, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 9, 2023
Reduction of anti-A and anti-B isoagglutinin titers of group O whole blood units employing an ABO antibody immune adsorption columnGaurav K Gupta, Kelly Henrichs, Kurt Nilsson, et al.
Emergency Medicine International|October 24, 2017
Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled TrialsMajed A Refaai, Truptesh H Kothari, Shana Straub, et al.
Pageof 9